FEATURED PUBLICATIONS
Showing 31 - 40 of 97
Published date : 11 October 2022
INOCA prevalence, diagnosis and management
Angina
Ischemia with non-obstructive coronary arteries, INOCA, shows a strong female predominance within the estimated 3-4 million individuals who suffer from it. INOCA can be diagnosed through invasive or non-invasive techniques, assessing coronary flow reserve and the Index of Microcirculatory Resistance. Despite...
Reviewed by
Z. Beketova
Published in
Current Problems in Cardiology (September 2022) 29:101420
Authors
Hansen B, Holtzman JN, Juszczynski C, et al
Published date : 11 October 2022
INOCA and quality of life: a review
Angina
Traditionally, clinicians have focused on obstructive coronary artery disease (CAD), yet over 2 in 5 patients with angina do not experience obstruction. Ischemia with non-obstructive coronary arteries, also known as INOCA, is now being increasingly recognised, yet there is a lack...
Reviewed by
Z. Beketova
Published in
International Journal of Cardiology (September 2022)
Authors
Gulati M, Khan N, George M, et al.
Published date : 10 October 2022
Microvascular Angina diagnosis and management: a review
Angina
Ischaemia in the absence of obstructive coronary artery disease (also known as INOCA) has increasingly been recognised through the detection of microvascular angina. Microvascular angina presents a risk factor for cardiac issues such as stroke or even death, with 4 in...
Reviewed by
Z. Beketova
Published in
European Cardiology Review (December 2021) 16e46
Authors
Aldiwani H, Mahdai S, Alhatemi G, Bairey Merz CN
Published date : 15 September 2022
Association of Postural Hypotension and Echocardiographic Parameters in Chronic Heart Failure Patients
Heart failure
Orthostatic hypotension is a frequent concomitant disorder and a common co-morbidity in heart failure. It has been associated with increased risk of mortality and cardiovascular morbidity. Prevalent orthostatic hypotension may precede the incidence of HF and atrial fibrillation. The aim of...
Reviewed by
G. Bozet, MD
Published in
Medical Journal of Cairo University
Authors
EM Mahfouz et al
Published date : 12 September 2022
Diabetes Mellitus and ischaemic heart disease: a review
Heart failure
Diabetes mellitus (DM) affects 180 million patients worldwide. It is present in up to 25% to 30% of all patients undergoing percutaneous coronary intervention (PCI). It is also associated with increased cardiovascular risk and mortality, and has long been recognized as...
Reviewed by
G. Bozet, MD
Published in
The Egyptian Journal of Hospital Medicine (April 2022) Vol. 87, Page 1236-1240
Authors
M. Al Awadi et al
Published date : 7 September 2022
Polypill Strategy in Secondary Cardiovascular Prevention
Angina
A polypill that includes key medications associated with improved outcomes (aspirin, angiotensin-converting–enzyme [ACE] inhibitor, and statin) has been proposed as a simple approach to the secondary prevention of cardiovascular death and complications after myocardial infarction. Dr. Fuster said: “The findings suggest...
Reviewed by
G. Bozet, MD
Published in
N Engl J Med. 2022 Aug 26.
Authors
Castellano JM, Pocock SJ, Bhatt DL, Quesada AJ, et al.
Published date : 5 September 2022
Coronary Microvascular Angina: A State-of-the-Art Review
Angina
Angina pectoris affects about 112 million people worldwide . Up to 60–70% of patients, undergoing invasive coronary angiography due to angina and demonstrable myocardial ischemia with provocative tests, do not have epicardial coronary disease obstructive enough to explain these symptoms. The...
Reviewed by
G. Bozet, MD
Published in
Front Cardiovasc Med. 2022 March
Authors
Spione F et al
Published date : 14 August 2022
Biomarkers-based personalized follow-up in chronic heart failure improves patient’s outcomes and reduces care associate cost
Heart failure
Heart failure (HF) is a major and growing medical and economic problem, with high prevalence and incidence rates worldwide.In an interventional study, A. Leon-Justel et al. (Spain) assessed the impact of a personalised follow-up procedure for Heart Failure (HF) on 192...
Reviewed by
G. Bozet
Published in
Health and Quality outcomes 2021
Authors
Leon-Justel A, Morgado Garcia-Polavieja JI, Alvarez-Rios AI, et al.
Published date : 14 August 2022
Evolving Roles of Optimal Medical Therapy and PCI in Chronic Coronary Syndrome Patients with Stable Angina
Angina
In this introductory review, William E Boden and Juan Carlos Kaski describe several key features of the ISCHEMIA Trial in depth. The authors summarise "the future of managing chronic stable angina and how best to synthesise recent clinical trials evidence with...
Reviewed by
G. Bozet
Published in
Cardiovasc Drugs Ther 2022
Authors
Boden W and Kaski JC
Published date : 14 August 2022
A year in heart failure: an update of recent findings
Heart failure
The overall prevalence of HF ranges from about 1.5% to 4% in developed countries. 2021 and 2022 saw many changes in the guidelines for the management of these patients with HF. One of the key aspect is the moving away from...
Reviewed by
S. Duarte
Published in
ESC Heart Fail. 2021 Dec;8(6):4370-4393
Authors
Stretti L, Coats Zippo D, AJS, Anker M et al